XML 46 R85.htm IDEA: XBRL DOCUMENT
v3.20.1

SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details) $ in Thousands | 3 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 28, 2020 USD ($) | Dec. 28, 2019 USD ($) | Sep. 28, 2019 USD ($) | Jun. 29, 2019 USD ($) | Mar. 30, 2019 USD ($) | Dec. 29, 2018 USD ($) | Sep. 29, 2018 USD ($) | Jun. 30, 2018 USD ($) | Mar. 28, 2020 USD ($) unit | Mar. 30, 2019 USD ($) | Mar. 31, 2018 USD ($)
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Number of business units | unit |  |  |  |  |  |  |  |  | 3 |  |
Net revenues by business unit |  |  |  |  |  |  |  |  | $ 980,902 | $ 953,159 | $ 888,743
Effect of exchange rates |  |  |  |  |  |  |  |  | (12,253) | (5,486) | (5,394)
Net revenues | $ 238,492 | $ 258,970 | $ 252,566 | $ 238,451 | $ 249,295 | $ 247,356 | $ 241,581 | $ 229,347 | 988,479 | 967,579 | 903,923
Operating (loss) income | 26,007 | $ 40,907 | $ 49,739 | $ (13,302) | 23,856 | $ 28,320 | $ 26,076 | $ 5,293 | 103,351 | 83,545 | 56,157
Effect of exchange rates |  |  |  |  |  |  |  |  | 7,920 | 8,367 | 4,060
Restructuring Costs and Asset Impairment Charges |  |  |  |  |  |  |  |  | (51,220) | (21,170) | (1,941)
Deal amortization |  |  |  |  |  |  |  |  | 25,746 | 24,803 | 26,013
Restructuring and Related Cost, Accelerated Depreciation |  |  |  |  |  |  |  |  | 24,530 | 19,126 | 0
Impairment of assets and other related charges (2) |  |  |  |  |  |  |  |  | (19,878) | (13,660) | (44,125)
European Medical Device Regulation Costs |  |  |  |  |  |  |  |  | 1,506 | 0 | 0
PCS2 accelerated depreciation and related costs |  |  |  |  |  |  |  |  | 133 | (2,726) | (3,011)
Gain on sale of assets (4) |  |  |  |  |  |  |  |  | 8,083 | 0 | 0
Depreciation and amortization |  |  |  |  |  |  |  |  | 110,289 | 109,418 | 89,247
Total long-lived assets | 253,399 |  |  |  | 343,979 |  |  |  | 253,399 | 343,979 | 332,156
Service [Member] |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net revenues |  |  |  |  |  |  |  |  | 19,830 | 19,906 | 20,574
Plasma products and services |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net revenues |  |  |  |  |  |  |  |  | 537,231 | 501,837 | 435,956
Blood Center products and services |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net revenues |  |  |  |  |  |  |  |  | 252,829 | 269,203 | 284,902
Hospital products and services |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net revenues |  |  |  |  |  |  |  |  | 198,419 | 196,539 | 183,065
United States |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net revenues |  |  |  |  |  |  |  |  | 646,204 | 606,845 | 548,731
Total long-lived assets | 186,488 |  |  |  | 269,849 |  |  |  | 186,488 | 269,849 | 236,603
Japan |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net revenues |  |  |  |  |  |  |  |  | 72,218 | 69,908 | 67,319
Total long-lived assets | 2,037 |  |  |  | 1,726 |  |  |  | 2,037 | 1,726 | 1,511
Europe |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net revenues |  |  |  |  |  |  |  |  | 153,347 | 164,504 | 164,226
Total long-lived assets | 10,143 |  |  |  | 11,200 |  |  |  | 10,143 | 11,200 | 13,696
Asia |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net revenues |  |  |  |  |  |  |  |  | 109,295 | 118,700 | 115,127
Total long-lived assets | 29,175 |  |  |  | 30,930 |  |  |  | 29,175 | 30,930 | 36,431
Other |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net revenues |  |  |  |  |  |  |  |  | 7,415 | 7,622 | 8,520
Total long-lived assets | 25,556 |  |  |  | 30,274 |  |  |  | 25,556 | 30,274 | 43,915
Japan |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net revenues by business unit |  |  |  |  |  |  |  |  | 460,637 | 426,781 | 363,254
Depreciation and amortization |  |  |  |  |  |  |  |  | 38,429 | 38,074 | 47,985
Total long-lived assets | 141,903 |  |  |  | 192,628 |  |  |  | 141,903 | 192,628 | 186,007
Blood Center |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net revenues by business unit |  |  |  |  |  |  |  |  | 325,661 | 335,557 | 347,373
Depreciation and amortization |  |  |  |  |  |  |  |  | 8,513 | 9,623 | 11,439
Total long-lived assets | 93,758 |  |  |  | 127,272 |  |  |  | 93,758 | 127,272 | 122,898
North America Plasma |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Depreciation and amortization |  |  |  |  |  |  |  |  | 63,347 | 61,721 | 29,823
Total long-lived assets | $ 17,738 |  |  |  | $ 24,079 |  |  |  | 17,738 | 24,079 | 23,251
Hospital |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Net revenues by business unit |  |  |  |  |  |  |  |  | 194,604 | 190,821 | 178,116
Operating Segments [Member] |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Operating (loss) income |  |  |  |  |  |  |  |  | 465,822 | 420,266 | 384,416
Operating Segments [Member] | Japan |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Operating (loss) income |  |  |  |  |  |  |  |  | 225,351 | 180,300 | 146,986
Operating Segments [Member] | Blood Center |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Operating (loss) income |  |  |  |  |  |  |  |  | 159,802 | 163,628 | 170,172
Operating Segments [Member] | Hospital |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Operating (loss) income |  |  |  |  |  |  |  |  | 80,669 | 76,338 | 67,258
Corporate, Non-Segment [Member] |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |
Corporate expenses (1) |  |  |  |  |  |  |  |  | $ (255,727) | $ (263,603) | $ (257,229)

X
- Definition Corporate Operating Expenses + References No definition available. + Details
Name: | hae_CorporateOperatingExpenses
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Effect of Exchange Rate on Revenues + References No definition available. + Details
Name: | hae_EffectofExchangeRateonRevenues
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Effect of Exchange Rates on Operating Income + References No definition available. + Details
Name: | hae_EffectofExchangeRatesonOperatingIncome
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition European Medical Device Regulation Costs + References No definition available. + Details
Name: | hae_EuropeanMedicalDeviceRegulationCosts
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Net Revenues, Before Foreign Exchange Impact + References No definition available. + Details
Name: | hae_NetRevenuesBeforeForeignExchangeImpact
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Restructuring and Turnaround Costs + References No definition available. + Details
Name: | hae_RestructuringandTurnaroundCosts
Namespace Prefix: | hae_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(2) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585 + Details
Name: | us-gaap_AdjustmentForAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585 + Details
Name: | us-gaap_DepreciationAndAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.3) -URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227 + Details
Name: | us-gaap_LegalFees
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599 + Details
Name: | us-gaap_NoncurrentAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment. + References No definition available. + Details
Name: | us-gaap_NumberOfReportingUnits
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition The net result for the period of deducting operating expenses from operating revenues. + References No definition available. + Details
Name: | us-gaap_OperatingIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of other expense (income) that is infrequent in occurrence or unusual in nature. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233 + Details
Name: | us-gaap_OtherNonrecurringIncomeExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585 + Details
Name: | us-gaap_RestructuringCostsAndAssetImpairmentCharges
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of accelerated depreciation charged against earnings associated with exit from or disposal of business activities or restructuring plan. + References No definition available. + Details
Name: | us-gaap_RestructuringReserveAcceleratedDepreciation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045 + Details
Name: | us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SegmentReportingInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_ProductOrServiceAxis=us-gaap_ServiceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=hae_PlasmaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=hae_BloodCenterMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=hae_HospitalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=country_JP
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=srt_EuropeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=srt_AsiaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=hae_OtherCountryorRegionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=country_JP
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=us-gaap_EMEAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=hae_NorthAmericaPlasmaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=hae_AmericasBloodCenterandHospitalandAsiaPacificMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |